102 related articles for article (PubMed ID: 8971792)
1. Evidence that lysosomal storage of proteolipids is a cell autonomous process in the motor neuron degeneration (mnd) mouse, a model of neuronal ceroid lipofuscinosis.
Lipman RD; Donohue LR; Hoppe P; Bronson RT
Neurosci Lett; 1996 Nov; 219(2):111-4. PubMed ID: 8971792
[TBL] [Abstract][Full Text] [Related]
2. Two related proteolipids and dolichol-linked oligosaccharides accumulate in motor neuron degeneration mice (mnd/mnd), a model for neuronal ceroid lipofuscinosis.
Faust JR; Rodman JS; Daniel PF; Dice JF; Bronson RT
J Biol Chem; 1994 Apr; 269(13):10150-5. PubMed ID: 8144516
[TBL] [Abstract][Full Text] [Related]
3. Neuronal ceroid lipofuscinosis (nclf), a new disorder of the mouse linked to chromosome 9.
Bronson RT; Donahue LR; Johnson KR; Tanner A; Lane PW; Faust JR
Am J Med Genet; 1998 May; 77(4):289-97. PubMed ID: 9600738
[TBL] [Abstract][Full Text] [Related]
4. Retinal degeneration in motor neuron degeneration: a mouse model of ceroid lipofuscinosis.
Chang B; Bronson RT; Hawes NL; Roderick TH; Peng C; Hageman GS; Heckenlively JR
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1071-6. PubMed ID: 8125718
[TBL] [Abstract][Full Text] [Related]
5. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment.
Cooper JD; Messer A; Feng AK; Chua-Couzens J; Mobley WC
J Neurosci; 1999 Apr; 19(7):2556-67. PubMed ID: 10087069
[TBL] [Abstract][Full Text] [Related]
6. Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid-lipofuscinosis.
Katz ML; Rice LM; Gao CL
J Neurosci Res; 1997 Oct; 50(1):123-32. PubMed ID: 9379488
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in mitochondria-associated membranes and phospholipid biosynthetic enzymes in the mnd/mnd mouse model of neuronal ceroid lipofuscinosis.
Vance JE; Stone SJ; Faust JR
Biochim Biophys Acta; 1997 Feb; 1344(3):286-99. PubMed ID: 9059519
[TBL] [Abstract][Full Text] [Related]
8. The development of behavioral abnormalities in the motor neuron degeneration (mnd) mouse.
Bolivar VJ; Scott Ganus J; Messer A
Brain Res; 2002 May; 937(1-2):74-82. PubMed ID: 12020865
[TBL] [Abstract][Full Text] [Related]
9. Motor neuron degeneration of mice is a model of neuronal ceroid lipofuscinosis (Batten's disease).
Bronson RT; Lake BD; Cook S; Taylor S; Davisson MT
Ann Neurol; 1993 Apr; 33(4):381-5. PubMed ID: 7683855
[TBL] [Abstract][Full Text] [Related]
10. An early-onset congenic strain of the motor neuron degeneration (mnd) mouse.
Messer A; Manley K; Plummer JA
Mol Genet Metab; 1999 Apr; 66(4):393-7. PubMed ID: 10191135
[TBL] [Abstract][Full Text] [Related]
11. Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis.
Guarneri R; Russo D; Cascio C; D'Agostino S; Galizzi G; Bigini P; Mennini T; Guarneri P
Brain Res; 2004 Jul; 1014(1-2):209-20. PubMed ID: 15213005
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of the adenosine triphosphate synthase subunit C in the mnd mutant mouse. A model for neuronal ceroid lipofuscinosis.
Pardo CA; Rabin BA; Palmer DN; Price DL
Am J Pathol; 1994 Apr; 144(4):829-35. PubMed ID: 8160780
[TBL] [Abstract][Full Text] [Related]
13. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system.
Bertamini M; Marzani B; Guarneri R; Guarneri P; Bigini P; Mennini T; Curti D
Eur J Neurosci; 2002 Dec; 16(12):2291-6. PubMed ID: 12492423
[TBL] [Abstract][Full Text] [Related]
15. Rate of accumulation of Luxol Fast Blue staining material and mitochondrial ATP synthase subunit 9 in motor neuron degeneration mice.
Rodman JS; Lipman R; Brown A; Bronson RT; Dice JF
Neurochem Res; 1998 Oct; 23(10):1291-6. PubMed ID: 9804285
[TBL] [Abstract][Full Text] [Related]
16. Genetics of primary and timing effects in the mnd mouse.
Messer A; Plummer J; MacMillen MC; Frankel WN
Am J Med Genet; 1995 Jun; 57(2):361-4. PubMed ID: 7668363
[TBL] [Abstract][Full Text] [Related]
17. In-utero and post-delivery supplementation of motor neuron degeneration mutant mice with polyunsaturated fatty acids does not alter the clinical or pathological course.
Bennett MJ; Boriack RL; Birch DG
Neuropediatrics; 1997 Feb; 28(1):82-4. PubMed ID: 9151333
[TBL] [Abstract][Full Text] [Related]
18. The motor neuron degeneration (mnd) gene acts intrinsically in motor neurons and peripheral fibroblasts.
Porter JC; Messer A; Peterson A
Mol Cell Neurosci; 1997; 9(3):185-93. PubMed ID: 9245501
[TBL] [Abstract][Full Text] [Related]
19. Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze.
Wendt KD; Lei B; Schachtman TR; Tullis GE; Ibe ME; Katz ML
Behav Brain Res; 2005 Jun; 161(2):175-82. PubMed ID: 15885820
[TBL] [Abstract][Full Text] [Related]
20. Deficient mitochondrial Ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis.
Kolikova J; Afzalov R; Surin A; Lehesjoki AE; Khiroug L
Cell Calcium; 2011 Dec; 50(6):491-501. PubMed ID: 21917311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
